Heart failure with mid-range ejection fraction: a transition phenotype?-Reference-Cited by-同舟云学术

Heart failure with mid-range ejection fraction: a transition phenotype?

Published:2017-09-25 Issue:12 Volume:19 Page:1635-1637
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Bayés-Genís Antoni¹,Núñez Julio²,Lupón Josep¹

Affiliation:

1. Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, and Department of Medicine, CIBERCV; Autonomous University of Barcelona; Barcelona Spain

2. Cardiology Department, Hospital Clínico Universitario, INCLIVA, and Departament of Medicine, CIBERCV; Universitat de València; València Spain

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference8 articles.

1. Developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Ponikowski;Eur J Heart Fail,2016

2. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%);Lam;Eur J Heart Fail,2014

3. Mid-range left ventricular ejection fraction: clinical profile and cause of death in ambulatory patients with chronic heart failure;Pascual-Figal;Int J Cardiol,2017

4. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF);Rickenbacher;Eur J Heart Fail,2017

5. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry;Chioncel;Eur J Heart Fail,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Failure with Mid-Range or Mildly Reduced Ejection Fraction in the Era of Sodium–Glucose Co-Transporter 2 Inhibitors: Do We Now Provide Better Care for the “Middle Child of HF”? Real-World Experience from a Single Clinical Centre;Journal of Cardiovascular Development and Disease;2024-05-31

2. Trajectories of Kidney Function in Heart Failure Over a 15-Year Follow-Up;JACC: Heart Failure;2024-05

3. LV Strain Superiority Over LVEF in HFmrEF;JACC: Advances;2023-11

4. Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction;Rational Pharmacotherapy in Cardiology;2023-08-17

5. Long-Term Trajectories of Biomarkers, Functional, and Echocardiographic Parameters in Patients with Chronic Heart Failure from Dilated or Ischaemic Cardiomyopathy;Cardiology;2023